FEATURED

Aerobiotix Announces FDA 510(k) Clearance of Medical Ultraviolet Air Filtration System

Upcoming Events

Follow us on social for the latest on Aerobiotix

Don't forget to tune in tomorrow afternoon for Maureen Spencer's presentation at the European Operating Room Nurses Association Virtual Congress. Register at http://ow.ly/1Kmx50ERyTG to hear her speak about OR air quality and risks.
#infectionprevention #covid19 #EORNA

Aerobiotix is proudly sponsoring Maureen Spencer on Saturday, May 29th at the European Operating Room Nurses Association Virtual Congress. Register at http://ow.ly/1hfC50ERyTH to hear her speak about OR air quality and risks.
#infectionprevention #covid19 #EORNA

Load More...
News

Aerobiotix welcomes Aerobiovac, the Exclusive Distributor for Canada

Aerobiotix is pleased to partner with Aerobiovac to bring our leading air disinfection technology to Canada.

Aerobiotix Announces FDA 510(k) Clearance of Medical Ultraviolet Air Filtration System

MIAMISBURG, Ohio–(BUSINESS WIRE)–Aerobiotix, Inc., a leading manufacturer of air treatment devices for hospitals and healthcare, today announced U.S. Food and Drug Administration (FDA) 510(k) clearance of the Aerocure-MD medical air purification system.

Events

APIC Annual Meeting

June 28-30,2021, Austin, TX
Connect with us

AORN Annual Meeting

August 8-10, 2021 Orlando, FL
Connect with us

DAVID KIRSCHMAN, M.D.

President and CEO

The founder and CEO is David Kirschman, M.D., a former physician with extensive experience as CEO, Director, Chief Scientific Officer and operator in the orthopedic and biologic medical device space. Dr. Kirschman holds 55 issued US Patents for a wide range of medical devices. He received his BS in Biological Science cum laude from Colorado State University and M.D. from University of Colorado School of Medicine.

GREGORY CARROLL PH.D.

Director Scientific Affairs

Dr. Carroll has extensive experience in ultraviolet and photonic science. Prior to joining Aerobiotix, he led the research and development group at Sunstar Engineering. He has a Ph.D. in chemistry from Columbia University and did his postdoctoral fellowship under Nobel laureate Prof. Ben Feringa at the University of Groningen, Netherlands, and Lawrence Berkeley National Laboratory.

TONY EMBREE

Chief Commercial Officer

Tony leads our global sales organization and commercialization strategy. Prior joining Aerobiotix, he was Senior Manager of Strategy at Stryker. He has led sales and marketing teams in multiple organizations including SurgiCount Medical, part of Patient Safety Technologies, INC (PSTX) as it expanded from 8 hospitals in 2008 to user base of 330 hospitals at time of acquisition in 2013.

COURTNEY ADAMS, Ph.D.

VP of Clinical and Medical Affairs

Dr. Adams leads our global clinical research and education initiatives as well as developing key opinion leaders to support our clinical mission. Prior to joining Aerobiotix, she held leading research and medical affairs roles at Biogen, Axogen, and MedPace. Dr. Adams holds Ph.D. in Pharmacology from University of Cincinnati.

ANTHONY DEFALCO

Vice President of Engineering

Anthony is a topflight medical device product development engineer and leader, experienced in the development and implementation of orthopedic, environmental, and electromechanical systems.

NATHAN UTZ

Vice President of Sales

Nathan brings a high level of commitment to servicing and building client relations. He was one of the first employees to start for Aerobiotix. Nathan has previously held leadership roles in the medical device industry. He received his BS from Antioch McGregor University Midwest.

MICHAEL SCHMITZ

Chief Financial Officer

Mr. Schmitz is a highly experienced financial practitioner with financial leadership roles in diverse industries including manufacturing and technology as well as a background in public accounting. He received his BS in accounting, cum laude, from the Miami University of Ohio. Mr. Schmitz is a certified public accountant and certified management accountant.